The CD4+ T cell subsets showed no difference between the WT and CCL5−/− tumor-bearing mice on day 3, but on day 14, the CCL5−/− tumor-bearing mice had higher levels of Th1 and lower levels of Tregs compared to the WT control mice. This evidence concerns the gene CD4 and neoplasm.